| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,640 |
6,676 |
$513K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,305 |
3,085 |
$160K |
| 36415 |
Collection of venous blood by venipuncture |
9,076 |
8,292 |
$33K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
269 |
262 |
$18K |
| 80061 |
Lipid panel |
1,190 |
1,165 |
$14K |
| 80053 |
Comprehensive metabolic panel |
1,226 |
1,180 |
$11K |
| 84443 |
Thyroid stimulating hormone (TSH) |
674 |
661 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,019 |
995 |
$8K |
| 85027 |
|
1,203 |
1,158 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,222 |
1,091 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
143 |
140 |
$4K |
| 99443 |
|
47 |
40 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
373 |
350 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
251 |
239 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
29 |
29 |
$2K |
| 99215 |
Prolong outpt/office vis |
32 |
25 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
89 |
88 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
13 |
13 |
$1K |
| 99000 |
|
82 |
79 |
$1K |
| 82607 |
|
66 |
62 |
$1K |
| 86003 |
|
20 |
12 |
$866.19 |
| 90662 |
|
33 |
29 |
$821.34 |
| 99442 |
|
46 |
31 |
$738.15 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
29 |
29 |
$722.97 |
| 85610 |
|
200 |
157 |
$664.14 |
| 81001 |
|
140 |
135 |
$427.46 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
145 |
135 |
$390.97 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$388.42 |
| G0008 |
Administration of influenza virus vaccine |
81 |
72 |
$344.83 |
| 90686 |
|
57 |
55 |
$271.73 |
| 99441 |
|
21 |
12 |
$257.57 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
13 |
12 |
$224.40 |
| 99421 |
|
58 |
50 |
$186.20 |
| 86803 |
|
12 |
12 |
$177.94 |
| 82728 |
|
14 |
12 |
$143.48 |
| 83550 |
|
12 |
12 |
$100.93 |
| 84439 |
|
13 |
13 |
$95.11 |
| 82043 |
|
13 |
12 |
$72.86 |